Isaac Fordjour has notable professional experience on healthcare, budget & appropriations, medicare & medicaid, tax, and copyright, patent & trademark issues. Isaac currently works full-time for Venable LLP and has previously worked for Cranmer Consultants, BOSTON SCIENTIFIC CORPORATION, and AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS .

Practice Areas

Areas of Experience

Boston Scientific Corporation
Duration : 3.7 years (2008 - 2011) active
Revenue : $20,000.00 (monthly) - $850,000.00 (total)
- ** see addendum page H.R. 756 - National Pain Care Policy Act, pain management S. 1213 Patient Centered Outcomes Research Act of 2009, comparative effectiveness S. 301 - Physician Payments Sunshine Act of 2009, disclosure H.R. 1346/S. 540 - Medical Device Safety Act of 2009, preemption Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act ***, no specific bill(s), import safety, price transparency, hea...

National Association of Insurance and Financial Advisors
Duration : 0.2 years (2016 - 2016) active
Revenue : $204,257.00 (monthly) - $612,770.00 (total)
- Issues related to agent compensation: H.R. 815. Issues related to the implementation of the Patient Protection and Affordable Care Act: H.R. 1624, H.R. 30, H.R. 588, S. 1099 and S. 30. Issues related to HSA/FSA reform. Issues related to the McCarran-Ferguson anti-trust exemption. Issues with respect to the small employer health care insurance tax credit including: S. 379, H.R. 762, H.R. 4469, S. 1653, S. 2045 and S. 2499.

Intel Corporation - Semiconductor design and manufacturing
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,667.00 (monthly) - $50,000.00 (total)
- Monitor proposed health information technology provisions issues

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- Public Law 112-144 - Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) specifically pertaining to user fees used to train FDA staff and streamline approval process Unique Device Identifiers (UDI) - Implementation of UDI rule H.R. 6 - 21st Century Cures Initiative - Legislation to accelerate the pace of biomedical innovation and cures by modernizing federal research and regulatory agencies Innovation for Healthier Americans (Senate, companion) - Legislation to ...

GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- Department of Labor, Health and Human Services, and Education FY17 funding (S.3040)related to call centers operated for the Centers for Medicare and Medicaid Services and all issues relating to health and medical IT for the Department of Health and Human Services; House Ways and Means, Energy and Commerce, Finance Committees and Senate Health, Education, Labor and Pension Committees.

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Duration : 0.2 years (2016 - 2016) active
Revenue : $7,824.00 (monthly) - $23,473.00 (total)
- RAISE Health Benefits Act (HR 1185)- expanding use of FSAs Health Savings Act (HR 1196)- expanding use of HSAs

Oracle Corporation
Duration : 0.2 years (2016 - 2016) active
Revenue : $6,667.00 (monthly) - $20,000.00 (total)
- Issues relating to state health exchanges under the Affordable Care Act

GlycoMimetics, Inc. - GlycoMimetics, Inc. specializes in small molecule therapeutics
Duration : 2.8 years (2009 - 2011) inactive
Revenue : $0.00 (monthly) - $90,000.00 (total)
- no specific bills Sickle Cell Anemia education and research advocacy

Alzheimer's Association - Advocacy association focused on Alzheimer care, support and research
Duration : 5.0 years (2009 - 2014) inactive
Revenue : $16,667.00 (monthly) - $890,000.00 (total)
- **see addendum page S. 1340/H.R. 2244/H.R. 467 - The Geriatric Assessment and Chronic Care Coordination Act of 2009, chronic care management and dementia. S. 697/H.R. 172 - The Community Living Assistance Services and Supports Act, all provisions relating to establishing a national, voluntary disability insurance program. H.R. 4872 - The Health Care and Education Affordability Reconciliation Act of 2010, care coordination, long-term care H.R. 3590 - The Patient Protection and Affordable Care...

Dendreon Corporation - Biotechnology Firm
Duration : 3.0 years (2011 - 2013) inactive
Revenue : $20,000.00 (monthly) - $770,000.00 (total)
- VA coverage and reimbursement

Thorn Run Partners - Government relations and communications
Duration : 3.2 years (2011 - 2014) inactive
Revenue : $10,000.00 (monthly) - $710,000.00 (total)
- **see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, implementation, comparative effectiveness research, debt ceiling negotiations, Joint Select Committee on Deficit Reduction Health care reform/comparative effectiveness research H.R. 2693, S. 365, S. 627 - Budget Control Act of 2011 H.R. 2560 - Cut, Cap and Balance Act of 2011 H.R. 2608, H.R. 2017 - Continuing Appropriations Act of 2012

National Coalition for Assistive and Rehab Technology
Duration : 0.5 years (2009 - 2009) inactive
Revenue : $10,000.00 (monthly) - $70,000.00 (total)
- Medicare benefit design and payment

BD (Becton, Dickinson and Company) - BD is a medical device technology company.
Duration : 2.5 years (2011 - 2014) inactive
Revenue : $20,000.00 (monthly) - $550,000.00 (total)
- **add addendum page PL 111-148 - The Patient Protection and Affordable Care Act, implementation FDA User Fee Reauthorizations S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - Patient Access to Medical Innovation Act S. 1995 Medical Device Patient Safety Act H.R. 3209 - Premarket Predictability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management...

Wyeth
Duration : 3.0 years (2007 - 2009) inactive
Revenue : $10,000.00 (monthly) - $510,000.00 (total)
- H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act of 2007 ***, no specific bill(s), Alzheimers Research, Hormone Replacement Therapy, Vaccine Program

JAZZ Pharmaceuticals Inc. - A specialty biopharmaceutical company
Duration : 2.0 years (2012 - 2014) inactive
Revenue : $20,000.00 (monthly) - $480,000.00 (total)
- PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bills, drug safety

3M - Diversified technology company.
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $26,667.00 (monthly) - $430,000.00 (total)
- **see addendum pageImplementation of the Patient Protection and Affordable Care Act (PL111-148) ***, no specific bills, ACOs, ICD-10, Sunshine Implementation of the Food and Drug Administration Safety and Innovation Act (PL112-144) Medical Device Tax H.R. 523, Protect Medical Innovation Act of 2013, and S. 232, Medical Device Access and Innovation Protection Act

PFIZER
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $26,667.00 (monthly) - $420,000.00 (total)
- **see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation, user fee sequester H.R. 2186 - Valid Compounding Act H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013, track and trace S. 959 - Pharmaceutical Compounding Quality and Accountability Act, track and trace H.R. 3204 The Drug Quality and Security Act H.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief

AMGEN INC
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $20,000.00 (monthly) - $400,000.00 (total)
- **see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation S. 959 - Pharmaceutical Compounding Quality and Accountability Act, track and trace H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013, track and trace H.R. 3204 The Drug Quality and Security Act ***, no specific bill, Prescription Drug User Fee Act (PDUFA) and associated policies

Pfizer - Pfizer provides access to safe, effective & affordable medicines & related health care svc
Duration : 0.2 years (2012 - 2012) inactive
Revenue : $13,333.00 (monthly) - $40,000.00 (total)
- coverage and reimbursement

Sanofi-Aventis
Duration : 1.5 years (2007 - 2008) inactive
Revenue : $20,000.00 (monthly) - $360,000.00 (total)
- ***, no specific bill(s), Deep Vein Thrombosis awareness

Blue Cross Blue Shield Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $33,333.00 (monthly) - $2,900,000.00 (total)
- H.R. 1368 - Personalized Health Information Act of 2007 S. 1783 - Ten Steps to Transform Health Care in America Act S. 1019 - Universal Health Care Choice and Access Act H.R. 1424 - Paul Wellstone Mental Health and Addiction Equity Act of 2007 ***, no specific bill(s), Blue Health Intelligence, Health Savings Accounts/Medical Savings Accounts, Transparency, Health Information Technology S. 558 - Mental Health Parity Act of 2007 H.R. 1663 - Medicare Mental Health Modernization Act of 2007 S...

NATIONAL MARROW DONOR PROGRAM
Duration : 7.2 years (2001 - 2008) inactive
Revenue : $32,897.00 (monthly) - $2,523,852.00 (total)
- H.R. 2764 (P.L. 110-161): Consolidated Appropriations Act, 2008 C.W. Bill Young Transplantation Program National Cord Blood Inventory

Biogen Idec - Medical Technology Firm
Duration : 1.0 years (2007 - 2007) inactive
Revenue : $40,000.00 (monthly) - $240,000.00 (total)
-

ANTHEM INC (FORMERLY KNOWN AS WELLPOINT INC )
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $30,000.00 (monthly) - $2,370,000.00 (total)
- **see addendum page H.R. 1/S. 350 - the "American Recovery and Reinvestment Act of 2009, health information technology." ***, no specific bill(s), Health Savings Accounts/Medical Savings Accounts, Transparency, Health Information Technology, Electronic Prescribing, Insurance Market Reform, Uninsured, Employer Based Health System, Health Care Reform.

Biotechnology Industry Organization - Represent organizations that promote research and support growth of biotechnology industry
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $2,230,000.00 (total)
- **see addendum page Human Growth Hormone Regulation S. 877/H.R. 4911 - "the Controlling the Abuse of Prescriptions Act of 2007" Biosimilars H.R. 1956 - " Patient Protection and Innovative Biologic Medicine Act of 2007" H.R. 1038 - "Access to Life-Saving Medicine Act, Follow-On Biologics" S. 1695 - "Biologics Price Competition and Innovation Act of 2007" H.R. 5629 - "the Pathway for Biosimilars Act" S. 2029 - "Physician Payments Sunshine Act of 2007, disclosure" H.R....

American HomePatient
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $16,667.00 (monthly) - $2,210,000.00 (total)
- H.R. 3590, "The Patient Protection and Affordable Care Act", oxygen reimbursement H.R. 4872, "The Health Care and Education Affordability Reconciliation Act of 2010", oxygen reimbursement

Mallinckrodt Pharmaceuticals - Pharmaceutical producer
Duration : 1.0 years (2013 - 2014) inactive
Revenue : $26,667.00 (monthly) - $210,000.00 (total)
- prescription drugs abuse and deterrence radiopharmaceuticals

AdvaMed - Medical device manufacturing trade association.
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,880,000.00 (total)
- **see addendum page S. 301/H.R. 3138 Physician Payments Sunshine Act of 2009, disclosure H.R. 1346/S. 540 Medical Device Safety Act of 2009, preemption H.R. 759 Food and Drug Administration Globalization Act S. 510 - FDA Food Safety Modernization Act S. 1213 Patient Centered Outcomes Research Act of 2009, comparative effectiveness H.R. 3590 - The Patient Protection and Affordable Care Act ***, no specific bill(s), import safety, health care reform

Amgen Inc - Biotechnology company
Duration : 5.8 years (2007 - 2012) inactive
Revenue : $20,000.00 (monthly) - $1,790,000.00 (total)
- *** see addendum page Biosimilars H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 5629 - the "Pathway for Biosimilars Act".

Healthcare Distribution Management Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,760,000.00 (total)
- **add addendum page S. 301 - Physician Payments Sunshine Act of 2009, disclosure S.__Affordable Health Choices Act, vaccine issues, pharmacy reimbursement

National Electrical Manufacturers Association (MITA)
Duration : 6.8 years (2007 - 2014) inactive
Revenue : $23,333.00 (monthly) - $1,650,000.00 (total)
- **see addendum page S. 2029 - Physician Payments Sunshine Act of 2007, Disclosure H.R. 5605 - Physician Payments Sunshine Act of 2008, Disclosure S. 1042, Consistency, Accuracy, Responsibility and Excellence in Imaging Act, to improve imaging S. 2449, Sunshine in Litigation Act of 2007, settlement disclosure H.Res. 1216 - a resolution to reduce unnecessary radiation exposure through CT scans to children ***no specific bill number, Import Safety

Juvenile Diabetes Research Foundation International
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,580,000.00 (total)
- **add addendum page Implementation of the Special Diabetes Program, renewal of the Special Diabetes Program H.R. 6309 - reauthorization of SDP S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516), medical device policies, accelerated approval, breakthrough therapies ***, no specific bill, artificial pancreas program

AstraZeneca
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,490,000.00 (total)
- **see addendum page S. 301/H.R. 3138 Physician Payments Sunshine Act of 2009, disclosure Biosimilars S. 726/H.R. 1427 Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 The Pathway for Biosimilars Act PL 111-148 The Patient Protection and Affordable Care Act, implementation, health care reform, drug importation, follow-on biologics, 340b, comparative effectiveness, gift disclosure, Medicaid and Medicare reimbursement

Vertex Pharmaceuticals Incorporated
Duration : 6.2 years (2008 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,470,000.00 (total)
- **see addendum page ***, no specific bill, Raising Awareness of Hepatitis C ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services, screening PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 3090 - Health Equity and Accountability Act of 2009, hepatitis awareness and screening H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 3711 Viral Hepatitis and Liver C...

PhRMA - Represents country's leading pharmaceutical research and biotechnology companies
Duration : 5.5 years (2008 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,380,000.00 (total)
- PL 111-148 - The Patient Protection and Affordable Care Act, implementation, comparative effectiveness

AbbVie Inc. - Biopharmaceutical company
Duration : 0.7 years (2013 - 2014) inactive
Revenue : $16,667.00 (monthly) - $130,000.00 (total)
- **see addendum pageS. 959 - Pharmaceutical Compounding Quality and Accountability Act, track and trace H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013, track and trace H.R. 3204 The Drug Quality and Security Act no specific bill - FDA implementation issues

Genzyme Corporation
Duration : 5.2 years (2009 - 2014) inactive
Revenue : $20,000.00 (monthly) - $1,220,000.00 (total)
- **see addendum page S. 1213 - Patient-Centered Outcomes Research Act of 2009, comparative effectiveness Biosimilars S. 726/H.R. 1427 Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 The Pathway for Biosimilars Act Health care reform, drug importation, 340b, biosimilars PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation
Boston Scientific Corporation
Duration : 3.7 years (2008 - 2011) active
Revenue : $20,000.00 (monthly) - $850,000.00 (total)
- **see addendum page S. 301/H.R. 3138 Physician Payments Sunshine Act of 2009, disclosure PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation ***, no specific bill(s), regulatory and reimbursement issues for medical devices in Medicare, remote monitoring H.R. 4213 - American Jobs and Closing Tax Loopholes Act of 2010, health care provisions, medicare physician reimbursement H.R. 5297 - Small Business Jobs and Credit Act of...

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- - Regulatory and Reimbursement Issues for Medical Devices in Medicare. - Implementation of Coverage, Coding and Reimbursement under 2003 Medicare Prescription Drug Improvement and Modernization Act. - HR 3162 Children's Health and Medicare Protection Act of 2007 - HR 976, Small Business Tax Relief Act of 2007 - Medicare Coverage of Intracranial Angioplasty and Stenting - Medicare Payment of Inpatient Hospital Services - S. 631 Remote Monitoring Access Act of 2007 - HR 5765 Medicare Remote Mon...

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Duration : 0.2 years (2016 - 2016) active
Revenue : $7,824.00 (monthly) - $23,473.00 (total)
- Repeal of the Medicare Independent Payment Advisory Board (HR 1190/S 141)

GlycoMimetics, Inc. - GlycoMimetics, Inc. specializes in small molecule therapeutics
Duration : 2.8 years (2009 - 2011) inactive
Revenue : $0.00 (monthly) - $90,000.00 (total)
- Sickle Cell Anemia education and research advocacy

Alzheimer's Association - Advocacy association focused on Alzheimer care, support and research
Duration : 5.0 years (2009 - 2014) inactive
Revenue : $16,667.00 (monthly) - $890,000.00 (total)
- **see addendum page H.R. 3590 - The Patient Protection and Affordable Care Act, care coordination, long-term care H.R. 4872 - The Health Care and Education Affordability Reconciliation Act of 2010, care coordination, long-term care S. 434 - Empowered at Home Act of 2009, a bill to amend title XIX of the Social Security Act to improve the State plan amendment option for providing home and cummunity based services under the Medicaid Program, and for other purposes.

Cathy Abernathy Consulting - on behalf of Care Level Management
Duration : 0.8 years (2007 - 2008) inactive
Revenue : $6,667.00 (monthly) - $80,000.00 (total)
- Medicare Demonstration Project

Dendreon Corporation - Biotechnology Firm
Duration : 3.0 years (2011 - 2013) inactive
Revenue : $20,000.00 (monthly) - $770,000.00 (total)
- Medicare coverage and reimbursement, ASP

National Coalition for Assistive and Rehab Technology
Duration : 0.5 years (2009 - 2009) inactive
Revenue : $10,000.00 (monthly) - $70,000.00 (total)
- Medicare benefit design and payment

BD (Becton, Dickinson and Company) - BD is a medical device technology company.
Duration : 2.5 years (2011 - 2014) inactive
Revenue : $20,000.00 (monthly) - $550,000.00 (total)
- - Medicare coverage and reimbursement, sunshine H.R. 2810 Medicare Patient Access and Quality Improvement Act of 2013, SGR

Wyeth
Duration : 3.0 years (2007 - 2009) inactive
Revenue : $10,000.00 (monthly) - $510,000.00 (total)
- *see addendum page Medicare Physician Reimbursement Package, Medicare and Medicaid Drug Reimbursement, Medicaid Rebate H.R. 3162 - Children's Health and Medicare Protection Act of 2007 ***, no specific bill(s), Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference

JAZZ Pharmaceuticals Inc. - A specialty biopharmaceutical company
Duration : 2.0 years (2012 - 2014) inactive
Revenue : $20,000.00 (monthly) - $480,000.00 (total)
- Regulation and reimbursement of biologics

3M - Diversified technology company.
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $26,667.00 (monthly) - $430,000.00 (total)
- **see addendum pageImplementation of the Patient Protection and Affordable Care Act (PL111-148) H.R. 2810 - Medicare Patient Access and Quality Improvement Act of 2013, SGR S. 1871 - SGR Repeal and Medicare Beneficiary Access Act of 2013 H.R. 4302 - Protecting Access to Medicare Act of 2014 ***, no specific bill, Medicaid data, Medicare and Medicaid reimbursement policies related to health care associated conditions, health care associated infections, readmissions, payment bundling, ACOs, Su...

PFIZER
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $26,667.00 (monthly) - $420,000.00 (total)
- Medicare coverage and payment policies

AMGEN INC
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $20,000.00 (monthly) - $400,000.00 (total)
- **see addendum page Medicare Coverage and Reimbursement Issues H.R. 5 - Protecting Access to Healthcare Act H.R. 8 - American Taypayer Relief Act of 2012, ESRD ***, no specific bill number, reimbursement issues, Medicare Part B reimbursement and coverage of dialysis products

Pfizer - Pfizer provides access to safe, effective & affordable medicines & related health care svc
Duration : 0.2 years (2012 - 2012) inactive
Revenue : $13,333.00 (monthly) - $40,000.00 (total)
- coverage and reimbursement

Sanofi-Aventis
Duration : 1.5 years (2007 - 2008) inactive
Revenue : $20,000.00 (monthly) - $360,000.00 (total)
- ***, no specific bill(s), Medicare Drug Reimbursement and Coding, Deep Vein Thrombosis

Kidney Care Council - Health care association
Duration : 1.7 years (2007 - 2008) inactive
Revenue : $13,333.00 (monthly) - $320,000.00 (total)
- ***, no specific bill(s), Medicare Physician Reimbursement Package, Medicaid, and Medicare Bundling and Reimbursement Issues ESRD Quality and Payment Issues H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S. 691/H.R. 1193 - Kidney Care Quality and Education Act of 2007

Blue Cross Blue Shield Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $33,333.00 (monthly) - $2,900,000.00 (total)
- **see addendum pagePL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 2810 - Medicare Patient Access and Quality Improvement Act of 2013, SGR S. 1871 - SGR Repeal and Medicare Beneficiary Access Act of 2013 H.R. 4302 - Protecting Access to Medicare Act of 2014 ***, no specific bill(s), Medicare, Medicare Fraud, Medicare Advantage, Medicaid, Electronic Prescribing, Health Care Reform Implementation, Medigap reform, Physician Payment Reform, Delivery System Reform...

Biogen Idec - Medical Technology Firm
Duration : 1.0 years (2007 - 2007) inactive
Revenue : $40,000.00 (monthly) - $240,000.00 (total)
-

ANTHEM INC (FORMERLY KNOWN AS WELLPOINT INC )
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $30,000.00 (monthly) - $2,370,000.00 (total)
- **see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 675 - Strengthening Medicare Anti-Fraud Measures Act of 2011 S. 454 - Strengthening Program Integrity and Accountability in Health Care Act of 2011 H.R. 5 - Protecting Access to Healthcare Act ***, no specific bill(s), Medicare, Medicare Fraud, Medicare Advantage, Medicare Part D, Medicaid, Electronic Prescribing, Dual Eligibles, Medigap, claims resolution

Biotechnology Industry Organization - Represent organizations that promote research and support growth of biotechnology industry
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $2,230,000.00 (total)
- **see addendum page H.R. 1424/S. 558 - Paul Wellstone Mental Health and Addiction Equity Act of 2007, Medicaid Rebates H.R. 1424 - Emergency Economic Stabilization Act ***, no specific bill(s), Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, MIPPA Technical Corrections.

American HomePatient
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $16,667.00 (monthly) - $2,210,000.00 (total)
- ***see addendum page ***, no specific bill(s), Medicare Inhalation Drug Therapies and Oxygen Reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity, debt ceiling negotiations, Joint Select Committee on Deficit Reduction H.R. 1041, Fairness in Medicare Bidding Act, competitive bidding

Mallinckrodt Pharmaceuticals - Pharmaceutical producer
Duration : 1.0 years (2013 - 2014) inactive
Revenue : $26,667.00 (monthly) - $210,000.00 (total)
- prescription drugs abuse and deterrence radiopharmaceuticals

AdvaMed - Medical device manufacturing trade association.
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,880,000.00 (total)
- **see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation ***, no specific bill(s), gainsharing, remote monitoring, diagnostics, medicare physician reimbursement; reimbursement for imaging and technology; value based purchasing, Accountable Care Organizations S. 756 - Medicare Data Access for Transparency and Accountability Act S. 668 - Health Care Bureaucrats Elimination Act, IPAB H.R. 675 - Strengthening M...

Carden & Associates - on behalf of the Transplant Pharmacy Coalition
Duration : 1.0 years (2007 - 2007) inactive
Revenue : $53,333.00 (monthly) - $180,000.00 (total)
- S. 2499 - Medicare, Medicaid, and SCHIP Extension Act of 2007, Medicare Part B supply fee for pharmaceuticals that bill for immunosuppressives ***, no specific bill(s), Medicare Part B supply fee for pharmacies that bill for immunosuppressives

Amgen Inc - Biotechnology company
Duration : 5.8 years (2007 - 2012) inactive
Revenue : $20,000.00 (monthly) - $1,790,000.00 (total)
- **add addendum page Medicare Coverage and Reimbursement Issues ***, no specific bill number, reimbursement issues, Medicare Part B reimbursement and coverage issues of dialysis products

Healthcare Distribution Management Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,760,000.00 (total)
- **see addendum pageReimbursement for prescription drugs - Average Sales Price (H.R. 800, H.R. 1416, S. 806) PPACA Implementation (PL 111-148) CMS - (Sunshine, AMP and NADAC) SGR (H.R. 2810, S. 1871)

National Electrical Manufacturers Association (MITA)
Duration : 6.8 years (2007 - 2014) inactive
Revenue : $23,333.00 (monthly) - $1,650,000.00 (total)
- **see addendum pagePL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation H.R. 351/S. 351 - Protecting Seniors' Access to Medicare Act of 2013, IPAB H.R. 2810 Medicare Patient Access and Quality Improvement Act of 2013, SGR S. 1871 - SGR Repeal and Medicare Beneficiary Access Act of 2013 ***, no specific bill(s), Medicare Coverage, Regulation and Reimbursement of Imaging Services, Medicare Physician Payment, Sunshine Act, equ...

Juvenile Diabetes Research Foundation International
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,580,000.00 (total)
- PL 111-148 - The Patient Protection and Affordable Care Act, implementation issues related to diabetes care

AstraZeneca
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,490,000.00 (total)
- **see addendum page PL 111-148 The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation, Medicare and Medicaid Drug Reimbursement, 340b, Innovation Center S. 668 - Health Care Bureaucrats Elimination Act, IPAB H.R. 452 Medicare Decisions Accountability Act of 2011 (IPAB) H.R. 3765/H.R. 3630/H.R. 3743 - Temporary Payroll Tax Cut Continuation Act of 2011, health care provisions ***, no specific bill(s), Medicare and Medicaid Drug Reimburseme...

Vertex Pharmaceuticals Incorporated
Duration : 6.2 years (2008 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,470,000.00 (total)
- Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.

PhRMA - Represents country's leading pharmaceutical research and biotechnology companies
Duration : 5.5 years (2008 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,380,000.00 (total)
- **add addendum page ***, no specific bill(s), Medicare and Medicaid Drug Reimbursement, Medicaid Rebate H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, Affordable Health Choices Act S._ America's Healthy Future Act of 2009

AbbVie Inc. - Biopharmaceutical company
Duration : 0.7 years (2013 - 2014) inactive
Revenue : $16,667.00 (monthly) - $130,000.00 (total)
- biosimilars and FDA implementation issues

Genzyme Corporation
Duration : 5.2 years (2009 - 2014) inactive
Revenue : $20,000.00 (monthly) - $1,220,000.00 (total)
- **see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, implementation, ESRD, clinical laboratory payment H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, medicare physician reimbursement H.R. 4851, The Continuing Extension Act of 2010, medicare physician reimbursement H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010, health care provisions, 340b, and AMP, technical component of anatomic pathology servi...
Boston Scientific Corporation
Duration : 3.7 years (2008 - 2011) active
Revenue : $20,000.00 (monthly) - $850,000.00 (total)
- S.Con.Res. 13 - the Senate budget resolution, reconciliation instructions, health care reform H.Con.Res. 85 - the House budget resolution, reconcilation instructions, health care reform

Intel Corporation - Semiconductor design and manufacturing
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,667.00 (monthly) - $50,000.00 (total)
- FY17 Department of Energy and Water Appropriations (H.R.2028 & S.2804)

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- Public Law No: 113-67 - Making continuing appropriations for fiscal year 2014, and for other purposes. Specifically provisions providing appropriations for the FDAs CDRH evaluation of medical technology. FY 2016 Agriculture Appropriations Bill (House) - FDA Funding FY 2016 Agriculture Appropriations Bill (Senate) - FDA Funding

MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Supported riders to Labor, Health and Human Services Education, and Related Agencies Appropriations Bill about reining in DOL and NLRB

GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- Issues and funding related to FY 17 Defense; Homeland Security; Commmerce, Justice, Science; Intelligence Classified Annex; Transportation; Banking and Financial Services. House and Senate Fiscal Year 2017 (H.R.5293, S.3000 & S.2943)Department of Defense issues and funding--including but not limited to: shipbuilding; submarines; Navy ship repair issues; ground vehicles; aircraft; communications systems; amphibious vehicles; classified programs; ammunition and weapon systems. House and Senat...

City of Hillsboro - City government
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- FY2017 Energy and Water Appropriations (HR 5055, S.2804)

Alzheimer's Association - Advocacy association focused on Alzheimer care, support and research
Duration : 5.0 years (2009 - 2014) inactive
Revenue : $16,667.00 (monthly) - $890,000.00 (total)
- **see addendum page budget resolution, reconciliation, health care reform, deficit reduction, funding for Alzheimer's programs H.Con.Res. 112, budget resolution for 2013 H.R. 5872, Sequestration Transparency Act of 2012 H.R. 8, American Taxpayer Relief Act of 2012

Dendreon Corporation - Biotechnology Firm
Duration : 3.0 years (2011 - 2013) inactive
Revenue : $20,000.00 (monthly) - $770,000.00 (total)
- budget resolution, reconciliation, health care reform, deficit reduction H.Con.Res. 112, budget resolution for 2013

BD (Becton, Dickinson and Company) - BD is a medical device technology company.
Duration : 2.5 years (2011 - 2014) inactive
Revenue : $20,000.00 (monthly) - $550,000.00 (total)
- **see addendum pagebudget resolution, reconciliation, deficit reduction, debt ceiling H.R. 3547, the Consolidated Appropriations Act, 2014

Wyeth
Duration : 3.0 years (2007 - 2009) inactive
Revenue : $10,000.00 (monthly) - $510,000.00 (total)
- S.Con.Res. 13 - the Senate budget resolution, reconciliation instructions, health care reform H.Con.Res. 85 - the House budget resolution, reconcilation instructions, health care reform

3M - Diversified technology company.
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $26,667.00 (monthly) - $430,000.00 (total)
- **see addendum pagebudget resolution, reconciliation, deficit reduction, debt ceiling, government shutdown, Continuing Resolution H.J.Res. 59, Continuing Appropriations Resolution, 2014

PFIZER
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $26,667.00 (monthly) - $420,000.00 (total)
- **see addendum pagebudget resolution, reconciliation, deficit reduction, debt ceiling, government shutdown, Continuing Resolution H.J.Res. 59, Continuing Appropriations Resolution, 2014

Sanofi-Aventis
Duration : 1.5 years (2007 - 2008) inactive
Revenue : $20,000.00 (monthly) - $360,000.00 (total)
- FDA Appropriations Critical Path Drug Safety Human Drug Review H. Con. Res. 99/S. Con. Res. 21 - Budget Resolution, Medicare and Medicaid Drug Reimbursement

Kidney Care Council - Health care association
Duration : 1.7 years (2007 - 2008) inactive
Revenue : $13,333.00 (monthly) - $320,000.00 (total)
- H.Res. 1190/S.Con.Res. 70/H.Con.Res. 312 - FY 2009 Budget Resolution, reconciliation instructions

Blue Cross Blue Shield Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $33,333.00 (monthly) - $2,900,000.00 (total)
- budget resolution, reconcilation, health care reform, deficit reduction, Medicare Advantage, Medigap, and Medicaid H.Con.Res. 112, budget resolution for 2013

NATIONAL MARROW DONOR PROGRAM
Duration : 7.2 years (2001 - 2008) inactive
Revenue : $32,897.00 (monthly) - $2,523,852.00 (total)
-

Biogen Idec - Medical Technology Firm
Duration : 1.0 years (2007 - 2007) inactive
Revenue : $40,000.00 (monthly) - $240,000.00 (total)
- *see addendum page

ANTHEM INC (FORMERLY KNOWN AS WELLPOINT INC )
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $30,000.00 (monthly) - $2,370,000.00 (total)
- S. 1710/H.R. 3043 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008 H.R. 2764 - Consolidated Appropriations Act, 2008 ***, no specific bill(s), Medicare Advantage Funding and Uninsured

Biotechnology Industry Organization - Represent organizations that promote research and support growth of biotechnology industry
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $2,230,000.00 (total)
-

American HomePatient
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $16,667.00 (monthly) - $2,210,000.00 (total)
- reconciliation instructions, health care reform (oxygen reimbursement) H.R. 4872, The Health Care and Education Affordability Reconciliation Act of 2010

AdvaMed - Medical device manufacturing trade association.
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,880,000.00 (total)
- S.Con.Res. 13 - the Senate budget resolution, reconciliation instructions, health reform H.Con.Res. 85 - the Senate budget resolution, reconciliation instructions, health reform

Amgen Inc - Biotechnology company
Duration : 5.8 years (2007 - 2012) inactive
Revenue : $20,000.00 (monthly) - $1,790,000.00 (total)
-

Healthcare Distribution Management Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,760,000.00 (total)
- budget resolution, reconciliation, health care reform H.Res. 1493, budget enforcement S.Con.Res. 60, budget resolution

National Electrical Manufacturers Association (MITA)
Duration : 6.8 years (2007 - 2014) inactive
Revenue : $23,333.00 (monthly) - $1,650,000.00 (total)
- **see addendum page budget resolution, reconciliation, health care reform, debt ceiling negotiations, Joint Select Committee on Deficit Reduction H.R. 2693, S. 365, S. 627 - Budget Control Act of 2011 H.R. 2560 - Cut, Cap and Balance Act of 2011 H.R. 2608, H.R. 2017 - Continuing Appropriations Act of 2012

Juvenile Diabetes Research Foundation International
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,580,000.00 (total)
- ***, no specific bill(s), Critical Path, FDA Appropriations, Artificial Pancreas Project H.Res. 1190/S.Con.Res. 70/H.Con.Res. 312 - FY 2009 Budget Resolution, NIH Type 1 funding renewal

AstraZeneca
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,490,000.00 (total)
- budget resolution, reconciliation, health care reform H.Res. 1493, budget enforcement S.Con.Res. 60, budget resolution PL 111-152, The Reconciliation Act of 2010

Vertex Pharmaceuticals Incorporated
Duration : 6.2 years (2008 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,470,000.00 (total)
- **see addendum pagebudget resolution, reconciliation, deficit reduction, debt ceiling, government shutdown, Continuing Resolution H.J.Res. 59, Continuing Appropriations Resolution, 2014

PhRMA - Represents country's leading pharmaceutical research and biotechnology companies
Duration : 5.5 years (2008 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,380,000.00 (total)
- Healthcare reform SCHIP reauthorization Medicare and Medicaid payment system changes Patents

AbbVie Inc. - Biopharmaceutical company
Duration : 0.7 years (2013 - 2014) inactive
Revenue : $16,667.00 (monthly) - $130,000.00 (total)
- budget resolution, reconciliation, deficit reduction, debt ceiling, Continuing Resolution H.R. 3547, the Consolidated Appropriations Act, 2014

Genzyme Corporation
Duration : 5.2 years (2009 - 2014) inactive
Revenue : $20,000.00 (monthly) - $1,220,000.00 (total)
- **see addendum pagebudget resolution, reconciliation, deficit reduction, debt ceiling, government shutdown, Continuing Resolution H.J.Res. 59, Continuing Appropriations Resolution, 2014

TAX

Boston Scientific Corporation
Duration : 3.7 years (2008 - 2011) active
Revenue : $20,000.00 (monthly) - $850,000.00 (total)
- PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation

New York Life Insurance Company - Seller of life insurance, annuities, and long term care insurance.
Duration : 0.2 years (2016 - 2016) active
Revenue : $26,667.00 (monthly) - $80,000.00 (total)
- Legislation and regulation affecting life insurance companies and their products, including capital standards, tax reform, policies related to securities and asset management, policies related to pensions and retirement security, and SIFI designations and other activities of the Financial Stability Oversight Council.

National Association of Insurance and Financial Advisors
Duration : 0.2 years (2016 - 2016) active
Revenue : $204,257.00 (monthly) - $612,770.00 (total)
- Issues related to the tax treatment of financial products such as life insurance, annuities, retirement savings plans, employer-provided qualified and non-qualified benefit programs, and health insurance: S. Amdt. 947, H.R. 27, H.R. 1544, H.R.1040, S. 155, H.R.362, H.R. 4294, S. 2505, H.R. 557, H.R. 4094, H.R. 4114, H.R. 4469, H.R. 3050 and S. 2750.

The Vanguard Group, Inc. - Mutual Funds
Duration : 0.2 years (2016 - 2016) active
Revenue : $20,000.00 (monthly) - $60,000.00 (total)
- General tax issues related to mutual funds; commodity related investments, savings; capital gains and dividend tax rates as they relate to mutual funds; security transaction tax proposals.

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- Comprehensive/Corporate Tax Reform - Includes lower corporate tax rate, research credit transition and "House Blueprint", and base erosion Senate Finance Tax Reform Discussion Draft - International Tax Reform Provisions - Tax Extender Provisions

Masco Corporation
Duration : 0.2 years (2016 - 2016) active
Revenue : $10,000.00 (monthly) - $30,000.00 (total)
- meetings in support of passage of HR 2315 and S. 386, Mobile Workforce State Tax Simplification Act, and Senate companion (House, Senate);

GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- Highway and Transportation Funding Act (H.R. 3038), Senate Finance Committee and House Ways and Means Committee on legislation and tax reform; aviation related user fees; and aircraft depreciation schedule. Any and all titles related to pension funding stabilization.

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Duration : 0.2 years (2016 - 2016) active
Revenue : $7,824.00 (monthly) - $23,473.00 (total)
- Permanent repeal of medical device excise tax (HR 160/S 149)

AMERICAN SOCIETY OF INTERIOR DESIGNERS
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- Tax reform -- regarding the extension of 179D program, depreciation programs, and a tax credit for home owners if they redesign their house to accommodate health or aging issues.

BD (Becton, Dickinson and Company) - BD is a medical device technology company.
Duration : 2.5 years (2011 - 2014) inactive
Revenue : $20,000.00 (monthly) - $550,000.00 (total)
- H.R. 523, Protect Medical Innovation Act of 2013, device tax repeal S. 232, Medical Device Access and Innovation Protection Act, device tax repeal Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act

Blue Cross Blue Shield Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $33,333.00 (monthly) - $2,900,000.00 (total)
- **see addendum pagePL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, Sections of Health Care Reform legislation pertaining to proposed annual insurer assessments, and proposed excise tax on high-value health insurance plans H.R. 903/S. 399 - The American Job Protection Act, insurer excise tax S. 603 - The Jobs and Premium Protection Act, insurer excise tax H.R. 763 - to repeal the annual fee on health insurance providers ***, no specifi...

ANTHEM INC (FORMERLY KNOWN AS WELLPOINT INC )
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $30,000.00 (monthly) - $2,370,000.00 (total)
- **see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, Sections of Health Care Reform legislation pertaining to proposed annual insurer assessments, and proposed excise tax on high-value health insurance plans S. 1049 - Small Business Health, insurer fee H.R. 1370 - To Repeal the Annual Fee on Health Insurance Providers Enacted by PPACA

Biotechnology Industry Organization - Represent organizations that promote research and support growth of biotechnology industry
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $2,230,000.00 (total)
- PL 111-148 The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation, pharmaceutical tax, therapeautic tax credit

AdvaMed - Medical device manufacturing trade association.
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,880,000.00 (total)
- H.R. 436 (H.R.488, H.R.734, S.17, S.262) - Protect Medical Innovation Act of 2011, device tax repeal

Healthcare Distribution Management Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,760,000.00 (total)
- LIFO Accounting Methodology

National Electrical Manufacturers Association (MITA)
Duration : 6.8 years (2007 - 2014) inactive
Revenue : $23,333.00 (monthly) - $1,650,000.00 (total)
- H.R. 3590, The Patient Protection and Affordable Care Act H.R. 4872, The Health Care and Education Affordability Reconciliation Act of 2010 medical device tax
GlycoMimetics, Inc. - GlycoMimetics, Inc. specializes in small molecule therapeutics
Duration : 2.8 years (2009 - 2011) inactive
Revenue : $0.00 (monthly) - $90,000.00 (total)
- Sickle Cell Anemia education and research advocacy

Wyeth
Duration : 3.0 years (2007 - 2009) inactive
Revenue : $10,000.00 (monthly) - $510,000.00 (total)
- **see addendum page Biosimilars H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/H.R. 1038 - Access to Life - Saving Medicine Act, Follow-On Biologics S. 1695 - Biologics Price Competition and Innovation Act of 2007 S. 1505 - Affordable Biologics for Consumers Act H.R. 5629 - Pathway for Biosimilars Act Import Safety H.R. 3610 - Food and Drug Import Safety Act of 2007 S. 3409 - Drug and Device Accountability Act of 2008 ...

JAZZ Pharmaceuticals Inc. - A specialty biopharmaceutical company
Duration : 2.0 years (2012 - 2014) inactive
Revenue : $20,000.00 (monthly) - $480,000.00 (total)
- Regulation and reimbursement of biologics

Sanofi-Aventis
Duration : 1.5 years (2007 - 2008) inactive
Revenue : $20,000.00 (monthly) - $360,000.00 (total)
- *** no specific bill(s), FDAAA Implementation

Biogen Idec - Medical Technology Firm
Duration : 1.0 years (2007 - 2007) inactive
Revenue : $40,000.00 (monthly) - $240,000.00 (total)
-

ANTHEM INC (FORMERLY KNOWN AS WELLPOINT INC )
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $30,000.00 (monthly) - $2,370,000.00 (total)
- *** see addendum page

Biotechnology Industry Organization - Represent organizations that promote research and support growth of biotechnology industry
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $2,230,000.00 (total)
- **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA and associated policies

Mallinckrodt Pharmaceuticals - Pharmaceutical producer
Duration : 1.0 years (2013 - 2014) inactive
Revenue : $26,667.00 (monthly) - $210,000.00 (total)
- prescription drugs abuse and deterrence radiopharmaceuticals

AdvaMed - Medical device manufacturing trade association.
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,880,000.00 (total)
- Import Safety H.R. 3610 Food and Drug Import Safety Act of 2007 ***no specific bills, Import Safety, Implementation of FDAAA, Preemption

Amgen Inc - Biotechnology company
Duration : 5.8 years (2007 - 2012) inactive
Revenue : $20,000.00 (monthly) - $1,790,000.00 (total)
-

Healthcare Distribution Management Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,760,000.00 (total)
- **see addendum page Importation of prescription drugs (S. 525/H.R. 1298/S. 1232) RX Pedigree Pharmacy Accreditation Delay (H.R. 3663)

AstraZeneca
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,490,000.00 (total)
- **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages

PhRMA - Represents country's leading pharmaceutical research and biotechnology companies
Duration : 5.5 years (2008 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,380,000.00 (total)
- **see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation S. 10, S. 954 - Agriculture Reform, Food, and Jobs Act of 2013 H.R. 2186 - Valid Compounding Act H.R. 3204 The Drug Quality and Security Act, implementation H.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies, user...

AbbVie Inc. - Biopharmaceutical company
Duration : 0.7 years (2013 - 2014) inactive
Revenue : $16,667.00 (monthly) - $130,000.00 (total)
- biosimilars and FDA implementation issues
Boston Scientific Corporation
Duration : 3.7 years (2008 - 2011) active
Revenue : $20,000.00 (monthly) - $850,000.00 (total)
- S. 515/H.R. 1260 - Patent Reform Act of 2009, intellectual property S. 610 - Patent Reform Act of 2009, intellectual property

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- H.R. 9 - Innovation Act - Comprehensive Patent Reform - a bill to address the problem of abusive patent litigation Trade Secrets - Yet to be introduced legislation to establish a federal civil cause of action for trade secret misappropriation. H.R. XX - Targeting Rogue and Opaque Letters Act (TROL Act) - Increases transparency and accountability in patent demand letters and provides the Federal Trade Commission (FTC) with the authority to levy fines on those who send deceptive demand letters ...

MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Educate members of Congress and Administration officials to work to prevent the importation of counterfeit automotive parts. Monitor S. 560 and H.R. 1027, the PARTS Act. Monitor S. 632, the STRONG Patents Act of 2015. Pushed inclusion of marketplaces known to sell counterfeit goods in Notorious Markets list. Supported H.R. 644.

AMERICAN SOCIETY OF INTERIOR DESIGNERS
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- Interior design profession - regarding the absence of interior design in federal copyright statutes.

PFIZER
Duration : 1.5 years (2012 - 2014) inactive
Revenue : $26,667.00 (monthly) - $420,000.00 (total)
- Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Biogen Idec - Medical Technology Firm
Duration : 1.0 years (2007 - 2007) inactive
Revenue : $40,000.00 (monthly) - $240,000.00 (total)
-

Biotechnology Industry Organization - Represent organizations that promote research and support growth of biotechnology industry
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $2,230,000.00 (total)
- S. 23 - The America Invents Act; H.R. 1249 - America Invents Act, patent reform ***, no specific bill(s), Intellectual Property

AdvaMed - Medical device manufacturing trade association.
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,880,000.00 (total)
- S. 515/H.R. 1260 - Patent Reform Act of 2009, intellectual property S. 610 - Patent Reform Act of 2009, intellectual property

Amgen Inc - Biotechnology company
Duration : 5.8 years (2007 - 2012) inactive
Revenue : $20,000.00 (monthly) - $1,790,000.00 (total)
- S. 1145/H.R. 1908 - Patent Reform Act of 2007 *** no specific bill(s), Biotechnology Patents

AstraZeneca
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,490,000.00 (total)
- S. 1145/H.R. 1908 - Patent Reform Act of 2007 ***, no specific bill(s), Intellectual Properity

Vertex Pharmaceuticals Incorporated
Duration : 6.2 years (2008 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,470,000.00 (total)
- Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.

PhRMA - Represents country's leading pharmaceutical research and biotechnology companies
Duration : 5.5 years (2008 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,380,000.00 (total)
- S. 515/H.R. 1260 - Patent Reform Act of 2009 S. 610 - Patent Reform Act of 2009 ***, no specific bill(s), Intellectual Property
Boston Scientific Corporation
Duration : 3.7 years (2008 - 2011) active
Revenue : $20,000.00 (monthly) - $850,000.00 (total)
- Free Trade Agreements, offsets and provisions related to medical devices

Intel Corporation - Semiconductor design and manufacturing
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,667.00 (monthly) - $50,000.00 (total)
- International trade issues on patent issues

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- Trade Promotion Authority (TPA) - Supporting passage of authority to expedite pending and future trade agreements, such as TPP Transpacific Partnership (TPP) - Supporting passage for greater regulatory harmonization across Asia-Pacific country members and to include transparency and procedural fairness provisions in the agreement. Transatlantic Trade & Investment Partnership (T-TIP) - Supporting passage for greater regulatory harmonization of product approvals and registration

MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Educated members of Congress and the Administration on the effects and impact of the Trans-Pacific Partnership (TPP) and the Transatlantic Trade and Investment Partnership (TTIP) on the motor vehicle supplier industry.

AdvaMed - Medical device manufacturing trade association.
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,880,000.00 (total)
- H.R. 3078 - US - Columbia Trade Promotion Agreement, offsets and provisions related to medical devices H.R. 3079 - US - Panama Trade Promotion Agreement, offsets and provisions related to medical devices H.R. 3080 - US - Korea Trade Promotion Agreement, offsets and provisions related to medical devices

National Electrical Manufacturers Association (MITA)
Duration : 6.8 years (2007 - 2014) inactive
Revenue : $23,333.00 (monthly) - $1,650,000.00 (total)
- **see addendum page Free Trade Agreements, offsets and provisions related to medical devices and imaging
BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- H.R. 4441 - Aviation Innovation, Reform and Re-authorization Act of 2016 - Limitations on aircraft transportation of lithium batteries S. 2658 - Federal Aviation Administration Re-authorization Act of 2016 - Limitations on aircraft transportation of lithium batteries H.R. 636 - FAA Extension - Limitations on aircraft transportation of lithium batteries

MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Educated members of congress on advanced safety technologies for heavy and light duty vehicles, and the importance of vehicle inspection programs. Advocated for regulatory incentives to encourage installation of advanced Heavy Duty vehicle safety technology. Discussed implementation of the FAST Act.

GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- Transportation, Housing and Urban Development (HUD)and related agencies -- issues and funding for Fiscal Year 2017 (H.R.5394 & S.2844), FAA certification issues, all general aviation related issues, commercial shipping and the shipbuilding industry regarding the Maritime Guaranteed Loan Program and the Jones Act.
BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- VHA Directive 2009-053 - Pain care directive - working to increase veteran access to pain specialists and FDA approved alternative treatments in the VHA. Public Law No 113-146 - Veterans Access, Choice, and Accountability Act: Implementation of law to allow veterans to seek healthcare from non-VA facilities if unable to receive care from the VA in a timely manner. VA Vendor Credentialing - Proposals to establish a national credentialing system for VA National Pain Strategy - Encouraging adapt...

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Duration : 0.2 years (2016 - 2016) active
Revenue : $7,824.00 (monthly) - $23,473.00 (total)
- Lobbying in support of VHA's decision not to grant full practice authority to CRNAs.
Intel Corporation - Semiconductor design and manufacturing
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,667.00 (monthly) - $50,000.00 (total)
- H.R.289, National STEM Education Tax Incentive or Teachers Act of 2011-Science and math education legislation

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- H.R. 1020 - STEM Education Act of 2015 (Smith). Bill to increase STEM Education H.R. 840 - STEM Gateways Act (Kennedy). Bill to increase STEM Education S. 402 - STEM Master Teacher Corps Act of 2015 (Franken). Bill to increase STEM Education S. 442 - Innovation Inspiration School Grant Program Act (Shaheen). Bill to increase STEM Education S. 1177 ESEA Bill, Specifically Provisions to provide more funding and access to after school STEM Programs

GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- All education, Senate HELP Committee and House Education and Workforce Committee related to authorization of the Higher Education Act and FAFSA form simplification (H.R. 5528 and S.3040).

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Duration : 0.2 years (2016 - 2016) active
Revenue : $7,824.00 (monthly) - $23,473.00 (total)
- Student Loan Interest Deduction Act (HR 509) - expands student loan interest deduction Student Loan Refinancing Act (HR 649) - would allow borrowers to refinance federal student loans Empowering Student Borrowers Act (S. 781)- requires higher ed institutions to provide financial literacy education Allow interest free forbearance and/or deferment for loans in the internship/residency status of either payment delay option.
Intel Corporation - Semiconductor design and manufacturing
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,667.00 (monthly) - $50,000.00 (total)
- Monitor proposed health information technology provisions issues

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- - HR 5465 Military Pain Care Act

GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- House and Senate Fiscal Year 2017 (H.R.5293, S.3000, & PL 114-328)Department of Defense issues and funding (research & development and procurement)related to: shipbuilding; submarines; ground vehicles; aircraft; communications systems; amphibious vehicles; defense intelligence programs; ammunition and weapon systems; military information support operations,
Intel Corporation - Semiconductor design and manufacturing
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,667.00 (monthly) - $50,000.00 (total)
- Cybersecurity issues (S.413)

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- H.R. 234 - Cyber Intelligence Sharing & Protection Act (CISPA) - A bill to promote industry and government sharing of cyber intelligence H.R. 85 / H.R. 1073 - Critical Infrastructure Protection Acts - Bills to make improvements regarding cyber security and critical infrastructure protection

Oracle Corporation
Duration : 0.2 years (2016 - 2016) active
Revenue : $6,667.00 (monthly) - $20,000.00 (total)
- Internet and data protection issues
New York Life Insurance Company - Seller of life insurance, annuities, and long term care insurance.
Duration : 0.2 years (2016 - 2016) active
Revenue : $26,667.00 (monthly) - $80,000.00 (total)
- Legislation and regulation affecting life insurance companies and their products, including capital standards, tax reform, policies related to securities and asset management, policies related to pensions and retirement security, SIFI designations and other activities of the Financial Stability Oversight Council; and issues related to the Department of Labors proposed changes to the definition of a fiduciary under the Employee Retirement Income Security Act.

National Association of Insurance and Financial Advisors
Duration : 0.2 years (2016 - 2016) active
Revenue : $204,257.00 (monthly) - $612,770.00 (total)
- Issues related to the implementation of the Dodd-Frank Wall Street Reform Act of 2010. Issues related to the regulation of securities products and those who sell them. Issues related to the regulation of certain employee benefit plan sponsors/participants and IRA holders under ERISA: H.R. 1090, S. 1317 and H.R. 2317. Issues related to investment advice provided by municipal advisors. Issues related to consumer compensation in instances of investment fraud. Issues related to the disclosure of...

The Vanguard Group, Inc. - Mutual Funds
Duration : 0.2 years (2016 - 2016) active
Revenue : $20,000.00 (monthly) - $60,000.00 (total)
- Dodd-Frank regulations - systemic risk, FSOC, SIFI issues and derivatives. Mutual fund issues, Money Market Fund regulations; ETFs; securities issues; market structure issues; and financial services issues; FSOC, SIFI issues (H.R. 1550; Section 302 of Financial Regulatory Improvement Act of 2015); H.R. 5983, Financial Choice Act.

GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- Issues related to the Export-Import Bank
AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Duration : 0.2 years (2016 - 2016) active
Revenue : $7,824.00 (monthly) - $23,473.00 (total)
- Lobbing to House and Senate Appropriations committee chairs and ranking members about NIDCR funding

National Electrical Manufacturers Association (MITA)
Duration : 6.8 years (2007 - 2014) inactive
Revenue : $23,333.00 (monthly) - $1,650,000.00 (total)
- Medical imaging regulation and reimbursement

Juvenile Diabetes Research Foundation International
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $26,667.00 (monthly) - $1,580,000.00 (total)
- H.R. 3/S. 5 - Stem Cell Research Enhancement Act of 2007 S. 1494/H.R. 2762 - To amend the Public Health Service Act to reauthorize the special diabetes programs for Type 1 diabetes and Indians under that Act, Funding of Type 1 Diabetes ***, no specific bill(s), Artificial Pancreas

Vertex Pharmaceuticals Incorporated
Duration : 6.2 years (2008 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,470,000.00 (total)
- Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
The Vanguard Group, Inc. - Mutual Funds
Duration : 0.2 years (2016 - 2016) active
Revenue : $20,000.00 (monthly) - $60,000.00 (total)
- Cybersecurity issues.

GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- Homeland Security Appropriations for Fiscal Year 2017 and all issues and funding related to USCIS, and the production of permanent resident and worker authorization credentials. Funding and issues related to Cyber programs; information systems; telecommunications; technology equipment; infrastructure; support and services; border protection; DHS Headquarters Consolidation Project. Issues related to the Cyber Intelligence Sharing and Protect Act (CISPA) and U.S. Coast Guard ship acquisition.
New York Life Insurance Company - Seller of life insurance, annuities, and long term care insurance.
Duration : 0.2 years (2016 - 2016) active
Revenue : $26,667.00 (monthly) - $80,000.00 (total)
- Legislation and regulation affecting life insurance companies and their products, including capital standards, tax reform, policies related to securities and asset management, policies related to pensions and retirement security, and SIFI designations and other activities of the Financial Stability Oversight Council.

National Association of Insurance and Financial Advisors
Duration : 0.2 years (2016 - 2016) active
Revenue : $204,257.00 (monthly) - $612,770.00 (total)
- Issues relating to insurance regulatory reform and agent compensation. Issues related to the implementation of of the Patient Protection and Affordable Care Act: H.R. 1624, S. 1099, H.R. 30, H.R. 588, and S. 30. Issues related to terrorism risk insurance: H.R. 26. Issues related to flood risk insurance. Issues related to the regulation of insurance competition, products with guarantees, individual and employer owned policies, and fiduciary-client relationships.

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Duration : 0.2 years (2016 - 2016) active
Revenue : $7,824.00 (monthly) - $23,473.00 (total)
- Dental and Optometric Care Act (HR 3323) - prohibits insurers from capping fees on noncovered dental services

Blue Cross Blue Shield Association
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $33,333.00 (monthly) - $2,900,000.00 (total)
- S. 358/H.R. 493 - Genetic Information Nondiscrimination Act of 2007

ANTHEM INC (FORMERLY KNOWN AS WELLPOINT INC )
Duration : 7.2 years (2007 - 2014) inactive
Revenue : $30,000.00 (monthly) - $2,370,000.00 (total)
- S. 358/ H.R. 493 - Genetic Information Nondiscrimination Act of 2007
GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- House and Senate FY 2017 Intelligence Community issues and funding for classified programs.
GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- Conducted meetings with House and Senate Commerce, Justice and Science Appropriations Committees, and with House and Senate Judiciary Committees related to ATF rulings in Nitrocellulose.
GENERAL DYNAMICS CORP
Duration : 0.2 years (2016 - 2016) active
Revenue : $969,868.00 (monthly) - $2,909,604.00 (total)
- House and Senate issues relating to FY16 FAA Reauthorization and FY17 NASA aeronautical programs.
National Association of Insurance and Financial Advisors
Duration : 0.2 years (2016 - 2016) active
Revenue : $204,257.00 (monthly) - $612,770.00 (total)
- Issues relating to the process and protocol of the federal regulatory system.

MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Supported S. 226 & H.R. 427, the REINS Act. Supported H.R. 185, the Regulatory Accountability Act. Supported H.R. 348, the RAPID Act. Supported H.R. 712, the Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2016.

AMERICAN SOCIETY OF INTERIOR DESIGNERS
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- Government Services Administration reform regarding the role of interior designers in working in federal buildings or bidding federal projects. S 535 and HR 873 - The Better Buildings Act of 2015 (full bill)- require the General Services Administration to develop and publish model leasing provisions to encourage building owners and tenants to use greater cost-effective energy and water efficiency measures in commercial buildings, and to develop policies and best practices to implement the me...
Intel Corporation - Semiconductor design and manufacturing
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,667.00 (monthly) - $50,000.00 (total)
- Border Security, Economic opportunity, and Immigration Modernization Act (S.744)

BOSTON SCIENTIFIC CORPORATION
Duration : 9.0 years (2008 - 2016) active
Revenue : $140,000.00 (monthly) - $4,950,000.00 (total)
- S. 744 - The Border Security Economic Opportunity and Immigration Modernization Act - Immigration Reform
Fuels America - Promote benefits of renewable fuel and protect Americas Renewable Fuel Standard
Duration : 0.2 years (2016 - 2016) active
Revenue : $23,333.00 (monthly) - $70,000.00 (total)
- Renewable Fuels Standard Maintenance; FY17 Interior and Environment Appropriations Act (H.R.5538 S.3068)

MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Supported S. 1408, H.R. 4106, the Vehicle Innovation Act and S. 1449, the Building Better Trucks Act. Supported S.2012. Had discussions regarding use of remaining ATVM loan authority. Educated Congress on supplier role in motor vehicle research & development. Encouraged passage of energy bill conference report.

Masco Corporation
Duration : 0.2 years (2016 - 2016) active
Revenue : $10,000.00 (monthly) - $30,000.00 (total)
- Meetings in support of WaterSense authorization in comprehensive energy bill (House, Senate)

AMERICAN SOCIETY OF INTERIOR DESIGNERS
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- S. 720. Energy Savings and Industrial Competitiveness Act of 2015 (full bill) - to increase U.S. energy productivity, enhance energy security, reduce emissions and promote economic growth.
National Association of Insurance and Financial Advisors
Duration : 0.2 years (2016 - 2016) active
Revenue : $204,257.00 (monthly) - $612,770.00 (total)
- Issues related to IRA and pension reform. Issues related to investment advice made in connection with retirement products: H.R. 1090, S. 1317 and H.R. 2317. Issues related to individuals and businesses investing in retirement vehicles, plan funding limits, participation and disclosure rules, exemptions, employer and plan sponsor duties and safe harbors: H.R. 4293, S. 2502, H.R. 506, S. 245, H.R. 3050 and H.R. 4094.
Fuels America - Promote benefits of renewable fuel and protect Americas Renewable Fuel Standard
Duration : 0.2 years (2016 - 2016) active
Revenue : $23,333.00 (monthly) - $70,000.00 (total)
- Renewable Fuels Standard Maintenance

Cloakroom Advisors on Behalf of Gephardt Gov't Affairs on Behalf of Bayer AG - Government Relations/ Agriculture and Pharmaceutical
Duration : 0.2 years (2016 - 2016) active
Revenue : $6,667.00 (monthly) - $20,000.00 (total)
- Federal review of corporate acquisition
Fuels America - Promote benefits of renewable fuel and protect Americas Renewable Fuel Standard
Duration : 0.2 years (2016 - 2016) active
Revenue : $23,333.00 (monthly) - $70,000.00 (total)
- Renewable Fuels Standard Maintenance

City of Hillsboro - City government
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- Issues related to water and hydro facilities. Water Infrastructure Financing Investment Act (WIFIA). Water Resources Reform and Development Act (PL 113-121). FY2017 Energy and Water Appropriations (HR 5055, S.2844). 2016 Water Resources Development Act (S. 2848, HR 5303). Regulations related to municipal water supply.
MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Educated Congress on the continued importation of asbestos containing brake pads. Monitored implementation of H.R. 2576, TSCA Reform Legislation.

Cloakroom Advisors on Behalf of Gephardt Gov't Affairs on Behalf of Bayer AG - Government Relations/ Agriculture and Pharmaceutical
Duration : 0.2 years (2016 - 2016) active
Revenue : $6,667.00 (monthly) - $20,000.00 (total)
- Federal review of corporate acquisition
MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Educated members of congress and administration officials on measures to safeguard or ensure safety of imported automotive parts. Educated policy makers about the proliferation of counterfeits in e-commerce. Shared information on markets known for selling fake auto parts.

Oracle Corporation
Duration : 0.2 years (2016 - 2016) active
Revenue : $6,667.00 (monthly) - $20,000.00 (total)
- Internet and data protection issues
MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Supported H.R. 4715 and S. 2659, the RPM Act of 2016.

City of Hillsboro - City government
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- Issues related to municipal water rights
Intel Corporation - Semiconductor design and manufacturing
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,667.00 (monthly) - $50,000.00 (total)
- Monitoring ICANN Transition H.R.5393 & S.2837, FY17 Commerce, Justice and Science Appropriations Act

Vertex Pharmaceuticals Incorporated
Duration : 6.2 years (2008 - 2014) inactive
Revenue : $16,667.00 (monthly) - $1,470,000.00 (total)
- Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Duration : 0.2 years (2016 - 2016) active
Revenue : $7,824.00 (monthly) - $23,473.00 (total)
- Prescription Drug Abuse Prevention - including the development of acute care prescribing guidelines

FamilyLinks - Help individuals and families who have issues behavioral problems
Duration : 0.2 years (2016 - 2016) active
Revenue : $0.00 (monthly) - $0.00 (total)
- Help in securing Federal grants and bill passage.
MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Supported H.J. Res. 29 and S.J. Res. 8, resolutions of disapproval of NLRB rules on so called "Ambush elections". Encouraged members to support S. 1298, legislation to provide nationally consistent measures of performance of the Nation's ports. Encouraged members of congress to support H. Res. 108, promoting swift resolution to contract negotiations, and support S. 1519, To amend the Labor Management Relations Act, 1947 to address slowdowns, strikes, and lock-outs occurring at ports in th...
MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Educate members of congress and administration officials on motor vehicle manufacturing industry, advancement of vehicle technology, creation of new vehicle components and systems that improve safety and fuel efficiency of motor vehicles. Met with staff to discuss implementation of the FAST Act.
MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Duration : 0.2 years (2016 - 2016) active
Revenue : $16,133.00 (monthly) - $48,400.00 (total)
- Educated members of Congress and the Administration about the need to preserve 5.9GHz spectrum, currently reserved by Department of Transportation (DOT) for pending wireless communications between vehicles. Monitored provisions of S. 424, the Wi Fi Innovation Act.
Masco Corporation
Duration : 0.2 years (2016 - 2016) active
Revenue : $10,000.00 (monthly) - $30,000.00 (total)
- meetings with House and Senate staffers on general manufacturing issues affecting Masco business units such as housing industry issues, plumbing industry issues (no specific bills); (House/Senate)
AMERICAN SOCIETY OF INTERIOR DESIGNERS
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015 (H.R. 241) (full bill) - Amends the Americans With Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time ...
AMERICAN SOCIETY OF INTERIOR DESIGNERS
Duration : 0.2 years (2016 - 2016) active
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- S. 3158 The ALLOW Act (full bill). Regarding DC policy on occupational licensing laws, which would establish an Office of Supervision of Occupational Boards in the office of the Attorney General for the District of Columbia, or another DC government agency, to be responsible for exercising active supervision over each covered DC occupational licensing board to ensure compliance with the policy.
MidFirst Bank - Treatment of FHA & VA Loans and Bankruptcy
Duration : 0.2 years (2016 - 2016) inactive
Revenue : $3,333.00 (monthly) - $10,000.00 (total)
- Legislative and Regulatory issues related to FHA; Flood Insurance Reform and implementation of the Dodd-Frank Act; the Consumer Financial Protection Bureau Examination and Reporting Threshold Act of 2015 (S. 482, H.R. 4099); the Financial Regulatory Improvement Act of 2015 (S. 1484); and the Financial CHOICE Act (H.R. 5983).

Top Expertise

  • HEALTHCARE
  • BUDGET & APPROPRIATIONS
  • MEDICARE & MEDICAID
  • TAX
  • COPYRIGHT
  • PATENT & TRADEMARK

Clients

Current

  • AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
  • AMERICAN SOCIETY OF INTERIOR DESIGNERS
  • BOSTON SCIENTIFIC CORPORATION
  • Boston Scientific Corporation
  • City of Hillsboro
  • Cloakroom Advisors on Behalf of Gephardt Gov't Affairs on Behalf of Bayer AG
  • FamilyLinks
  • Fuels America
  • GENERAL DYNAMICS CORP
  • Intel Corporation
  • MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
  • Masco Corporation
  • National Association of Insurance and Financial Advisors
  • New York Life Insurance Company
  • Oracle Corporation
  • The Vanguard Group, Inc.

Past

  • 3M
  • AMGEN INC
  • ANTHEM INC (FORMERLY KNOWN AS WELLPOINT INC )
  • AbbVie Inc.
  • AdvaMed
  • Alzheimer's Association
  • American HomePatient
  • Amgen Inc
  • AstraZeneca
  • BD (Becton, Dickinson and Company)
  • Biogen Idec
  • Biotechnology Industry Organization
  • Blue Cross Blue Shield Association
  • Carden & Associates
  • Cathy Abernathy Consulting
  • Dendreon Corporation
  • Genzyme Corporation
  • GlycoMimetics, Inc.
  • Healthcare Distribution Management Association
  • JAZZ Pharmaceuticals Inc.
  • Juvenile Diabetes Research Foundation International
  • Kidney Care Council
  • Mallinckrodt Pharmaceuticals
  • MidFirst Bank
  • NATIONAL MARROW DONOR PROGRAM
  • National Coalition for Assistive and Rehab Technology
  • National Electrical Manufacturers Association (MITA)
  • PFIZER
  • Pfizer
  • PhRMA
  • Sanofi-Aventis
  • Thorn Run Partners
  • Vertex Pharmaceuticals Incorporated
  • Wyeth